Atrás
Rango del Día
$17.19
$18.87
Rango de 52 Semanas
$16.80
$29.16
Volumen
440,081
Promedio 50D / 200D
$19.69
/
$19.69
Cierre Anterior
$18.18
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -22.6 | 0.3 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -2957.6 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | — | 0.2 |
Precio Objetivo de Analistas
Hold
$31.00
+66.4%
EPS Futuro
-$0.20
Ingresos Est.
62 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2026 |
-$0.20
-$0.21 – -$0.19
|
62 M | 1 |
Puntos Clave
Generating 11.90M in free cash flow
Capital intensive — 192.47% of revenue goes to capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROICN/A
Net Margin-2957.63%
Op. Margin-3500.34%
Seguridad
Debt / Equity
N/A
Current Ratio15.98
Interest Coverage0.00
Valoración
P/E Ratio
-22.58
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.49M | Net Income (TTM) | -43.98M |
| ROE | N/A | ROA | -13.48% |
| Gross Margin | 100.00% | Operating Margin | -3500.34% |
| Net Margin | -2957.63% | Free Cash Flow (TTM) | 11.90M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 15.98 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -22.58 | P/B Ratio | N/A |
| P/S Ratio | 667.74 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 992.92M | Enterprise Value | 967.77M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | 1.49M | 0.0 | 0.0 |
| Net Income | -43.98M | -28.64M | -17.93M |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.49M | 0.0 | 0.0 |
| Operating Income | -52.05M | -34.79M | -19.76M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | 326.18M | 122.36M | 138.32M |
| Total Liabilities | 413.98M | 168.66M | 157.55M |
| Shareholders' Equity | -87.80M | -46.31M | -19.23M |
| Total Debt | 12.01M | 13.40M | 1.78M |
| Cash & Equivalents | 37.16M | 29.51M | 128.60M |
| Current Assets | 300.85M | 100.20M | 132.48M |
| Current Liabilities | 18.82M | 6.24M | 5.28M |